Riskpilot← Back to searchSign inGet full accessHartung Consulting Med Tech AB
ABActiveOrg 5591283915Rosenhöjdsvägen 1Business and other management consultancy activities · NACE 7020Est. 20170 employees
Revenue 2024
SEK 147K
-89% vs 2023
EBITDA margin
-197.8%
-127% vs 2023
Equity ratio
42.2%
Financial strength
Net profit 2024
SEK -10K
-102% vs 2023
| Revenue | SEK 147K | -89% |
| EBITDA | SEK -291K | -127% |
| Net profit | SEK -10K | -102% |
| Total assets | SEK 1,3M | -64% |
| Equity | SEK 562K | -14% |
| Employees | 0 | — |
Legal name
Hartung Consulting Med Tech AB
Org number
5591283915
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
9 oktober 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamhetens primära syfte är tekniska och medicinska mätningar och observationer, samt vetenskapliga föreläsningar inom tvärfunktionella områden. Samtliga konsultaktiviteter gäller som bas för ett organisationsutvecklande hos uppdragsgivarna. Sekundär verksamhet är författande och konsertverksamhet.
Address
Rosenhöjdsvägen 1
Email
carl.fredrik.hartung@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 321 | 748 | 1 314 | 147 |
| Staff expenses | — | — | −159 | −96 | 25 |
| EBITDA | −316 | −42 | 334 | 1 093 | −291 |
| Depreciation & amort. | −0 | −0 | −31 | −30 | — |
| EBIT | −316 | −42 | 303 | 1 063 | −291 |
| Net financials | — | −10 | −15 | −51 | −73 |
| Profit before tax | −316 | −53 | 288 | 758 | −10 |
| Tax | −0 | −0 | — | −157 | — |
| Net profit | −316 | −53 | 288 | 602 | −10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 159 | 481 | 826 | 3 681 | 1 330 |
| Equity | 25 | 25 | 313 | 652 | 562 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 134 | 456 | 513 | 2 776 | 685 |
| Total debt | 134 | 456 | 513 | 2 776 | 685 |
EBITDA margin
-197.8%
This company
15.8%
Market median
-1352% vs market
20202024
Equity ratio
42.2%
This company
38.2%
Market median
+10% vs market
20202024
Return on equity
-1.7%
This company
18.4%
Market median
-109% vs market
20202024
Net profit margin
-6.6%
This company
8.1%
Market median
-181% vs market
20202024
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20202024
Debt / equity
1.37×
This company
0.62×
Market median
-121% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hartung Consulting Med Tech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tore Carl Fredrik Hartung | Board of Directors | 0 companies |
| Laurie Anne Hartung | Deputy Board Member | 0 companies |
| Sebastian Eric Buks | Deputy Board Member | 0 companies |